GW PHARMA LTD (2016) Use of cannabinoids in the treatment of degenerative skeletal muscle disease. WO2016059411.

Preview

Text (Patent publication document) - Published Version · Please see our End User Agreement before downloading. 1MB

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Official URL: https://worldwide.espacenet.com/publicationDetails...

Download Statistics

Download Statistics

Download Statistics

Downloads

Downloads per month over past year

Funded Project

Funded Project

Funded Project

Funders:	Harrison's Fund Ltd	The sponsoring bodies who contributed funding for the creation of this item. Example: NERC Example: The Royal Society of Chemistry A pick list of funders may appear as you type in the funder's name in full or as an acronym. Select a correct match to complete the field or type in a new entry in full. For new entries, the full name is preferred.
Projects:	Assessing the therapeutic impact of cannabidiol on muscle structure and function in a preclinical mouse model of Duchenne Muscular Dystrophy. Funded by: Harrison's Fund Ltd (20131128 - £93,263) Local Lead (PI): Keith Foster 1 October 2014 - 31 March 2016	Click Add to select your project (received at Reading) from an autocomplete list.

Deposit Details

Deposit Details

Deposit Details

Date Deposited:	30 May 2018 09:38	Date item deposited into CentAUR
Last Modified:	05 Oct 2021 00:19	Date item last modified

University Staff: Request a correction | Centaur Editors: Update this record